| 1 |
Kato T, Kakuta Y, Abe T, et al. The benefits of cancer screening in kidney transplant recipients: a single-center experience[J]. Cancer Med, 2016, 5(2):153-158.
|
| 2 |
Koff JL, Waller EK. Improving cancer-specific outcomes in solid organ transplant recipients: Where to begin？[J]. Cancer, 2019, 125(6):838-842.
|
| 3 |
Hall EC, Pfeiffer RM, Segev DL, et al. Cumulative incidence of cancer after solid organ transplantation[J]. Cancer, 2013, 119(12):2300-2308.
|
| 4 |
Zhang J, Ma L, Xie Z, et al. Epidemiology of post-transplant malignancy in Chinese renal transplant recipients: a single-center experience and literature review[J]. Med Oncol, 2014, 31(7):32.
|
| 5 |
Tessari G, Naldi L, Boschiero L, et al. Incidence of primary and second cancers in renal transplant recipients: a multicenter cohort study[J]. Am J Transplant. 2013, 13(1):214-221.
|
| 6 |
张书新，刘阳. 肾移植术后并发原发性肺癌的单中心研究[J]. 南方医科大学学报，2017, 37(6):715-720.
|
| 7 |
Detterbeck FC, Boffa DJ, Kim AW, et al. The eighth edition lung cancer stage classification[J]. Chest, 2017, 151(1):193-203.
|
| 8 |
郑荣寿，孙可欣，张思维，等. 2015年中国恶性肿瘤流行情况分析[J]．中华肿瘤杂志，2019, 41(1): 19-28.
|
| 9 |
Rousseau-Gazaniol C, Fraboulet S, Couderc LJ, et al. Lung cancer in renal transplant recipients: A case-control study[J]. Lung Cancer, 2017, 111:96-100.
|
| 10 |
Rosenbaum DH, Bhojani RA, Dikmen E, et al. Routine computed tomography screening of the chest in high-risk cardiac transplant recipients may improve survival[J]. J Heart Lung Transplant, 2005, 24(12):2043-2047.
|
| 11 |
粟大明，邓文锋，刘如敏，等. 肾移植术后新发恶性肿瘤：单中心经验[J]. 器官移植，2020, 11(4):449-454.
|
| 12 |
王莉，何凡，卢一平，等. 肾移植术后肺癌临床分析[J]. 现代预防医学，2008, 35(12):2368-2369.
|
| 13 |
李新长，龙成美，杨华，等. 肾移植术后新发恶性肿瘤17例临床分析[J/CD]. 中华移植杂志：电子版，2017, 11(2):90-92.
|
| 14 |
Yanik EL, Siddiqui K, Engels EA. Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis[J]. Cancer Med, 2015, 4(9):1448-1459.
|
| 15 |
Reshef R, Vardhanabhuti S, Luskin MR, et al. Reduction of immunosuppression as initial therapy for posttransplantation lymphoproliferative disorder[J]. Am J Transplant, 2011, 11(2):336-347.
|
| 16 |
Boils CL, Aljadir DN, Cantafio AW. Use of the PD-1 pathway inhibitor nivolumab in a renal transplant patient with malignancy[J]. Am J Transplant, 2016, 16(8):2496-2497.
|
| 17 |
杨瑜. 肺癌靶向药物治疗研究进展[J]. 中国药师，2019, 22(1):140-143.
|